Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | AMGN | GILD | CELG | BIIB |
| Company | Cara Therapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7262 | 309.53 | 65.18 | 108.01 | 220.67 |
| High | 0.7790 | 314.60 | 65.22 | 108.59 | 222.91 |
| Low | 0.7250 | 306.32 | 64.52 | 107.27 | 218.88 |
| Last | 0.7601 | 312.86 | 64.58 | 108.24 | 222.75 |
| Change | +0.0270 | +5.55 | -0.34 | +0.11 | +3.03 |
| % Change | +3.68% | +1.81% | -0.52% | +0.10% | +1.38% |
| Volume | 126,700 | 2,921,300 | 6,048,500 | 191,230,496 | 754,500 |
| 20-Day Average Volume | 282,410 | 2,907,275 | 7,462,300 | 16,188,930 | 1,357,070 |
| Previous Close | 0.7331 | 307.31 | 64.92 | 108.13 | 219.72 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7326 | 279.47 | 66.10 | 108.17 | 206.41 |
| 20-Day Raw Stochastic | 64.37% | 84.27% | 5.83% | 63.25% | 99.52% |
| 20-Day Relative Strength | 48.88% | 68.03% | 31.74% | 64.69% | 59.71% |
| Weighted Alpha | -71.11 | +35.65 | -21.62 | +46.30 | -25.42 |
| Today's Opinion | 56% Sell | 56% Buy | 100% Sell | 100% Buy | 56% Sell |
| Previous Opinion | 88% Sell | 56% Buy | 100% Sell | 100% Buy | 56% Sell |
| Last Month's Opinion | 32% Sell | 40% Sell | 100% Sell | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.57% since 05/02/24 | +12.38% since 05/02/24 | -1.15% since 05/02/24 | -1.97% since 11/13/19 | +4.33% since 05/02/24 |
| Low | 0.7100 on 05/08/24 | 297.52 on 05/06/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 213.11 on 05/03/24 |
| High | 0.8315 on 05/06/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 222.91 on 05/09/24 |
| 1-Month | |||||
| %Chg | -8.64% since 04/09/24 | +15.72% since 04/09/24 | -7.66% since 04/09/24 | +5.14% since 10/18/19 | +7.86% since 04/09/24 |
| Low | 0.6311 on 04/16/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 |
| High | 0.8315 on 05/06/24 | 322.60 on 05/03/24 | 69.76 on 04/10/24 | 110.70 on 11/13/19 | 222.91 on 05/09/24 |
| 3-Month | |||||
| %Chg | +34.34% since 02/09/24 | +7.47% since 02/09/24 | -12.34% since 02/09/24 | +13.63% since 08/20/19 | -7.56% since 02/09/24 |
| Low | 0.5200 on 02/13/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 |
| High | 1.1500 on 03/04/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | -31.52% since 11/09/23 | +18.48% since 11/09/23 | -13.87% since 11/09/23 | +14.14% since 05/20/19 | -0.85% since 11/09/23 |
| Low | 0.5000 on 01/25/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 1.3100 on 12/15/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 40,076 | 164,851,840 | 80,830,400 | 77,035,920 | 31,990,572 |
| Shares Outstanding, K | 54,667 | 536,435 | 1,245,077 | 711,714 | 145,597 |
| Annual Sales | 20,970,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -118,510,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 3,000,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 2,290,500,000 |
| Last Quarter Net Income | -32,340,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | 393,400,000 |
| 60-Month Beta | 0.74 | 0.60 | 0.22 | 1.41 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 03/04/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.12 | 16.24 | 10.99 | 14.59 |